Professional Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-936
Closed -$41K 346
2022
Q3
$41K Buy
936
+1
+0.1% +$49 0.03% 157
2022
Q2
$49K Buy
935
+1
+0.1% +$51 0.03% 146
2022
Q1
$48K Buy
934
+1
+0.1% +$52 0.02% 147
2021
Q4
$55K Buy
933
+1
+0.1% +$50 0.02% 163
2021
Q3
$40K Buy
932
+1
+0.1% +$44 0.02% 157
2021
Q2
$36K Buy
931
+578
+164% +$22.5K 0.02% 167
2021
Q1
$13K Sell
353
-150
-30% -$5.33K 0.01% 226
2020
Q4
$19K Buy
503
+131
+35% +$4.8K 0.02% 198
2020
Q3
$13K Buy
+372
New +$13K 0.01% 207

Other funds holding PFE

Professional Financial Advisors's PFE Position: Q4 2022 in Review

Professional Financial Advisors sold out of Pfizer (PFE) in Q4 2022, closing a stake of 936 shares — an estimated $41K sold.

Professional Financial Advisors first reported a position in PFE in Q3 2020 and held it in 9 quarters. The position peaked at $55K in Q4 2021. 3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Professional Financial Advisors reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Professional Financial Advisors sold 936 Pfizer shares in Q4 2022, an estimated $41K.
  • Professional Financial Advisors first reported a position in Pfizer in Q3 2020 and held it in 9 quarters.
  • Professional Financial Advisors's Pfizer position peaked at $55K in Q4 2021.
  • 3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Professional Financial Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.